title: Characterization of the striatal dopaminergic neurotransmission in MEN2B mice with elevated cerebral tissue dopamine.
abstract: The Ret receptor tyrosine kinase is the common signaling receptor for the glial cell line-derived neurotrophic factor (GDNF) family ligands. The Met918Thr mutation leads to constitutive activation of Ret and is responsible for dominantly inherited cancer syndrome MEN2B. Previously, we found that the mice carrying the mutation (MEN2B mice) have profoundly increased tissue dopamine (DA) concentrations in the striatum as well as increased striatal levels of tyrosine hydroxylase (TH) and dopamine transporter. The aim of this study was to characterize the striatal dopaminergic neurotransmission in MEN2B mice and to clarify the mechanisms by which they compensate their over-production of DA. We found that tyrosine hydroxylase activity and DA synthesis are increased in MEN2B mice. Augmented effects of alpha-methyl-para-tyrosine (alphaMT, an inhibitor of TH) and tetrabenazine (VMAT2 blocker) on DA levels suggest that also storage of DA is increased in MEN2B mice. There was no difference in the basal extracellular DA concentrations or potassium-evoked DA release between the genotypes. The effects of cocaine and haloperidol were also similar between the genotypes as assessed by in vivo microdialysis. However, with in vivo voltammetry we found increase in stimulated DA release in MEN2B mice and detailed analysis of DA overflow showed that uptake of DA was also enhanced in MEN2B mice. Thus, our data show that enhanced synthesis of DA leading to increased storage and releasable pools in pre-synaptic terminals in MEN2B mice apparently also leads to increased DA release, which in turn is compensated by higher dopamine transporter activity.
authors.affiliation: Division of Pharmacology and Toxicology, Faculty of Pharmacy, University of Helsinki, Finland. jelena.mijatovic@helsinki.fi
authors.forename: Jelena
authors.initials: J
authors.lastname: Mijatovic
authors.forename: Outi
authors.initials: O
authors.lastname: Patrikainen
authors.forename: Leonid
authors.initials: L
authors.lastname: Yavich
authors.forename: Mikko
authors.initials: M
authors.lastname: Airavaara
authors.forename: Liisa
authors.initials: L
authors.lastname: Ahtee
authors.forename: Mart
authors.initials: M
authors.lastname: Saarma
authors.forename: T Petteri
authors.initials: TP
authors.lastname: Piepponen
mesh_terms: D000818:Animals; D003342:Corpus Striatum / Q000378:metabolism / Q000502:physiology*; D004298:Dopamine / Q000096:biosynthesis* / Q000235:genetics / Q000378:metabolism; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008817:Mice, Mutant Strains; D018814:Multiple Endocrine Neoplasia Type 2b / Q000235:genetics / Q000378:metabolism* / Q000503:physiopathology*; D009435:Synaptic Transmission / Q000502:physiology*; D015854:Up-Regulation / Q000235:genetics
chemical_list: D004298:Dopamine